Data / Form D filings / BRICKELL BIOTECH, INC.
BRICKELL BIOTECH, INC.: Form D filings
BRICKELL BIOTECH, INC., a pharmaceuticals company in Miami, FL, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on February 19, 2015, reports $7.3 million sold of a $10 million offering to 30 investors.
Find out what BRICKELL BIOTECH, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2600 SW 3RD AVENUE, SUITE 350, Miami, FL, 33129
- Phone
- (786) 304-2083
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1497233
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2015 | New notice | $10,000,000 | $7,268,189 | $2,731,811 | 30 | Feb 4, 2015 | sec.gov |
| Aug 13, 2014 | New notice | $3,000,000 | $2,214,600 | $785,400 | 24 | Jul 31, 2014 | sec.gov |
| Mar 7, 2013 | New notice | $7,000,000 | $3,573,899 | $3,426,101 | 26 | Feb 21, 2013 | sec.gov |
| Jul 22, 2010 | New notice | $6,200,000 | $6,199,987 | $13 | 13 | Jul 16, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gerard S. Coombs, CPA | Executive Officer | |
| Andrew J. Sklawer | Executive Officer | |
| William D. Ju | Director | |
| Charles J. Betlach, Ph.D. | Executive Officer | |
| George B. Abercrombie | Director | |
| Charles W. Stiefel | Director | |
| Reginald L. Hardy | Executive Officer, Director | |
| Richard C. Bulman, Jr. | Executive Officer | |
| David W. Angulo | Executive Officer | |
| Dennison T. Veru | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Feb 16, 2015 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BRICKELL BIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.